CCM

Catalio Capital Management Portfolio holdings

AUM $479M
1-Year Est. Return 140.7%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+140.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
-$87.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$31.3M
2
+$18.2M
3
+$17.6M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$15.5M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$14.2M

Top Sells

1
+$31.4M
2
+$27.9M
3
+$25M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$23M
5
GILD icon
Gilead Sciences
GILD
+$17.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBOT
51
BridgeBio Oncology
BBOT
$659M
– –
-410,700
GRAL
52
GRAIL Inc
GRAL
$2.86B
– –
-30,313
PVLA
53
Palvella Therapeutics
PVLA
$1.65B
– –
-10,452
BLLN
54
BillionToOne Inc
BLLN
$4.81B
– –
-25,505
1 2
3